Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Choline salicylate is the choline salt of salicylic acid and belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs). It acts as an analgesic, antipyretic, and anti-inflammatory agent. Choline salicylate works by inhibiting cyclooxygenase (COX), thereby reducing prostaglandin synthesis responsible for pain, inflammation, and fever. It is used to treat mild to moderate pain, reduce fever and inflammation or swelling in conditions such as arthritis (including rheumatoid arthritis), gout, rheumatic fever, muscle injuries in both adults and children. The drug is available in oral forms for systemic use and topical gels for localized relief (e.g., mouth lesions or dental procedures). At higher doses it can act as an anticoagulant antagonistic to vitamin K[1][4][5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on choline salicylate.